We are live on ! Find out more
ZDA

Zweig-DiMenna Associates Portfolio holdings

AUM $722M
1-Year Est. Return 97.69%
This Fund
S&P 500
This Quarter Est. Return
+8.46%
1 Year Est. Return
+97.69%
3 Year Est. Return
+317.96%
5 Year Est. Return
+499.45%
10 Year Est. Return
+3,067.75%
AUM
$2.39B
AUM Growth
+$63.6M
Cap. Flow
-$34.2M
Cap. Flow %
-1.43%
Top 10 Hldgs %
25.81%
Holding
359
New
101
Increased
47
Reduced
82
Closed
90

Sector Composition

Rank Sector Weight
1 Healthcare 20.55%
2 Consumer Discretionary 12.37%
3 Communication Services 10.42%
4 Financials 9.77%
5 Technology 9.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLXP
351
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
-68,700
Closed -$7.9M
PETM
352
DELISTED
PETSMART INC
PETM
-3,200
Closed -$260K
SWY
353
DELISTED
SAFEWAY INC
SWY
-14,300
Closed -$502K
COV
354
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
-517,495
Closed -$52.9M
ATVI
355
DELISTED
Activision Blizzard
ATVI
-722,920
Closed -$14.6M
HOT
356
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
-203,470
Closed -$16.5M
CELG
357
DELISTED
Celgene Corp
CELG
-90,351
Closed -$10.1M
CB
358
DELISTED
CHUBB CORPORATION
CB
-2,400
Closed -$248K
AGN
359
DELISTED
Allergan Inc
AGN
-370,471
Closed -$78.8M

Similar funds

Zweig-DiMenna Associates's Q1 2015 Portfolio in Review

As of Q1 2015, Zweig-DiMenna Associates held 359 positions worth $2.39B, up 2.7% from $2.32B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Zweig-DiMenna Associates's Q1 2015 filing shows 101 new, 47 increased, 82 reduced and 90 closed positions. Its largest new stake was Medtronic: 1,100,263 shares worth $85.8M. The largest sale was Allergan Inc, an estimated $78.8M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Zweig-DiMenna Associates's largest Q1 2015 buy was Medtronic: 1,100,263 shares worth $85.8M.
  • Zweig-DiMenna Associates added most to Baker Hughes in Q1 2015, an estimated $86.2M increase.
  • Zweig-DiMenna Associates's biggest Q1 2015 reduction was Baidu, cutting an estimated $33.4M.
  • Zweig-DiMenna Associates fully exited Allergan Inc in Q1 2015, selling an estimated $78.8M.
  • Zweig-DiMenna Associates's ten largest holdings make up 26% of its $2.39B portfolio in Q1 2015.
  • Zweig-DiMenna Associates opened 101 new positions and closed 90 in Q1 2015.
  • Zweig-DiMenna Associates's portfolio value rose 2.7% quarter-over-quarter to $2.39B.

Based on Zweig-DiMenna Associates's 13F filing for Q1 2015, filed 11 May 2015.